Zika Virus Market Exhibits a Lucrative Growth Potential during 2020-2025 | International Key Vendors - GSK, Sanofi, Bharat Biotech, Inovio Pharma, Intrexon, Cerus, NewLink Genetics

Overview of Global Zika Virus Market:

This report provides in-depth study of "Global Zika Virus Market 2020" using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Zika Virus Market report also provides an in-depth survey of key players in the market organization.

According to the market research study, the Zika Virus is a mosquito borne disease that affects pregnant women and their foetus the most. No vaccine against Zika virus has been developed yet and given the ongoing research, a cure or vaccine to treat the Zika virus remains years away. During the sudden Zika virus outbreak in 2016, there was a rapid increase in the use of POCT diagnostic tests. The research on the Zika virus point-of-care testing market considers two types of POCT tests, i.e. IgG and IgM Antibody Rapid Test and ELISA kits. As per the analysis reports, the market is expected to be dominated by ELISA kits, reaching a market size of over $4400 Million by the end of 2020.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/213798 .

Geographically, North America is expected to dominate the market studied. The growth can be attributed to the rising awareness of the advantages of testing kits. The government organizations, such as the Centers for Disease Control and Prevention (CDC), Pan American Health Organization (PAHO), etc., have been mainly involved in the prevention of Zika virus infection. Additionally, the developed healthcare infrastructure, along with rapid technological advancements by several biopharmaceutical companies in the testing of the Zika Virus is expected to positively impact the market.

Through the statistical analysis, the report depicts the international Zika Virus Market including capacity, production, production value, cost/profit, supply/demand and global import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2020-2025 market development trends of Zika Virus industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

Global Key Vendors:

1 Bharat Biotech

2 Inovio Pharmaceuticals and GeneOne Life Sciences

3 Intrexon

4 Cerus

5 Sanofi

6 NewLink Genetics

7 Immunovaccine

8 GlaxoSmithKline (GSK) and More.................

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Zika Virus Market Report 2020" @ https://www.businessindustryreports.com/buy-now/213798/single .

Product Type Segmentation

1 Sexual Transmission

2 Blood Transfusion

Industry Segmentation

1 Hospitals

2 Clinics

3 Ambulatory Surgery Centers

Current Medical Industry News:

Sanofi (March 30, 2020) - Sanofi: First patient outside U.S. treated in global Kevzara (sarilumab) clinical trial program for patients with severe COVID-19 - The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19. The global clinical program has now been initiated in Italy, Spain, Germany, France, Canada, Russia and the United States - all countries that have been impacted by COVID-19.

This is the second multi-center, double-blind, Phase 2/3 trial as part of the Kevzara COVID-19 program, and the companies are continuing to work with health authorities around the world to secure initiation at additional sites. This follows Sanofi and Regeneron's announcement earlier this month of the initiation of the first trial, which is U.S.-based.

"Sanofi and Regeneron are relentlessly working to rapidly initiate trials around the world that will help determine whether Kevzara has the potential to play a role in addressing the COVID-19 global health crisis. These trials will provide important data to determine whether Kevzara ameliorates the life-threatening complications of COVID-19 infections by counteracting the overactive inflammatory responses in the lungs when damaged by the virus. In these unprecedented times, we are deeply grateful for the daily collaboration with health authorities that are enabling us to conduct this clinical work so quickly," said John Reed, M.D., Ph.D., Sanofi's Global Head of Research and Development. "In addition to this clinical trial aiming to help critically ill COVID-19 patients, our work continues to bring forth a vaccine for disease prevention, along with efforts to provide other important Sanofi medicines that may help patients impacted by COVID-19."

Kevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. IL-6 may play a role in driving the overactive inflammatory response in the lungs of patients who are severely or critically ill with COVID-19 infection. The role of IL-6 is supported by preliminary data from a single-arm study in China using another IL-6 receptor inhibitor.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/213798 .

Major Points in Table of Contents:

Global Zika Virus Market Report 2020

1 Zika Virus Product Definition

2 Global Zika Virus Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Zika Virus Shipments

2.2 Global Manufacturer Zika Virus Business Revenue

2.3 Global Zika Virus Market Overview

3 Manufacturer Zika Virus Business Introduction

3.1 Bharat Biotech Zika Virus Business Introduction

3.2 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Business Introduction

3.3 Intrexon Zika Virus Business Introduction

3.4 Cerus Zika Virus Business Introduction

3.5 Sanofi Zika Virus Business Introduction

3.6 NewLink Genetics Zika Virus Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.